Life Sciences Market Research Reports

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

  1. 26 Oct 2015  |  Asia Pacific  |  Market Research

    Asia-Pacific Regulations Driving Innovation in Healthcare

    Innovative Public-Private Initiatives Attracting Investment in Research & Development

    The following article is an abstract of some recent whitepapers developed by Frost & Sullivan on the evolving regulatory policies impacting healthcare in Asia-Pacific (APAC). Government initiatives and incentives in the APAC have resulted in increasing investment in research and development (R&D) in healthcare, while free trade economics across the...

    $1,500.00
  2. 30 Sep 2015  |  Global  |  Market Research

    A Product and Pipeline Analysis of the Global Immunoglobulin Market

    Trends in Communicable and Non-Communicable Diseases Drug Pipeline

    Immunoglobulin therapies are life-saving medicines that have been in use for more than 60 years. They provide the patient with a variety of antibodies and are often used as a last line of defense in many severe inflammatory diseases. In some conditions, they are life-saving. However, immunoglobulin therapies are expensive. Despite this, global dem...

    $4,950.00
  3. 29 Sep 2015  |  Global  |  Technology Research

    Advances in monoclonal antibody therapeutics

    Monoclonal antibody therapeutics are being used for treatment of a wide array of diseases, specially in therapeutic areas such as oncology, immunology (including autoimmune and inflammatory diseases, as well as, transplant rejection) and neuroscience. The development of these new molecular agents, successfully directed to specific cellular targets,...

    $4,950.00
  4. 29 Sep 2015  |  Global  |  Market Research

    Insights for CFOs betting on Intellectual Property

    Type 2 diabetes is one of the most significant global health concerns of modern times. The size of the diabetes therapeutics market has stimulated a vast and growing pipeline of potential new therapies aimed at the unmet needs of tighter glucose control, improved safety profiles, and greater convenience to patients. This research service evaluates ...

    $4,950.00
  5. 29 Sep 2015  |  Global  |  Market Research

    Global Review of Intellectual Property (IP) Funds

    Big pharma companies increasingly consider outsourcing manufacturing to CMOs as a strategic move because of the uncomplicated, timely, and cost-effective services CMOs provide as well as the fact that companes can then focus on their core competencies. This study provides market overview, market engineering measurements, revenue forecasts, competit...

    $4,950.00
  6. 29 Sep 2015  |  Global  |  Technology Research

    Transforming cancer treatment with Immunotherapy (TechVision)

    Fight cancer with Immunotherapy

    This research service focuses on the current status of candidates for opioid therapeutics with a focus on current Phase 3 candidates, detailed timelines, rational for pivotal program design, Phase 2 data review and key opinion leader (KOL) commentary. A pipeline assessment is provided for all active candidates in development. The information contai...

    $4,950.00
  7. 28 Sep 2015  |  Asia Pacific  |  Market Research

    End-User Perspectives on the SEA RIS/ PACS Market

    Next-generation Imaging IT Needs Will Focus on Interoperability

    Picture archiving communication systems (PACS) were a real game changer 3 decades ago when, in combination with radiology information systems (RIS), they enabled rapid digitalization of medical imaging data. Today, Southeast Asia again stands at the brink of transformation as RIS PACS enter their second or third generation of deployment. In an effo...

    $4,950.00
  8. 03 Sep 2015  |  Asia Pacific  |  Market Research

    Impact of Policies Shaping ASEAN Healthcare—Outlook till 2020

    Policies Raising Standards and Lowering Barriers Across ASEAN

    The research service provides an analysis of the policies impacting the healthcare market in the Association of Southeast Asian Nations (ASEAN). It includes the current trends, market size, revenue forecast, and market drivers and restraints. Healthcare market participants and key opinion leaders were interviewed to obtain their perception about tr...

    $2,450.00
  9. 02 Sep 2015  |  Asia Pacific  |  Market Research

    Analysis of the Global Human Albumin Market and Product Pipeline

    Emerging Economies and Use of Human Albumin as an Excipient Present New Growth Opportunities

    The infectious disease IVD market in Indonesian presents diversified growth potential for different tiers of participants. Domestic participants stand to gain from the growth momentum in the lower-end market, whereas foreign leading manufacturers dominate the higher-end market. This research service analyses the infectious disease IVD market and p...

    $4,950.00
  10. 02 Sep 2015  |  Global  |  Market Research

    The New Age of Regenerative Medicine

    Why Stem Cell Therapy?

    Cell therapy is the fastest growing segment of the Regenerative Medicine (RM) industry. It comprises both immune cell therapy and stem cell therapy; however, stem cell therapy makes up the largest part of this segment. The global cell therapy market is driven by the success of stem cell treatments in treating or curing life-threatening diseases suc...

    $1,500.00